Histogenics Corporation to Present at 18th Annual BIO CEO & Investor Conference
WALTHAM, Mass., Jan. 26, 2016 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a regenerative medicine company focused on developing and commercializing products in the musculoskeletal space, today announced that Adam Gridley, …